Nexentis Technologies NXTS
NASDAQ NXTS
$0.62 -0.03 (-3.92%)
At close: Oct 20, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) EPS (Diluted) (2022 - 2026)

Updated

Nexentis Technologies (NXTS) reported EPS (Diluted) of -$13.66 for Q2 2026, compared with -$1.24 a year earlier.

Analysis

Nexentis Technologies (NXTS) EPS (Diluted) (2022 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Nexentis Technologies' EPS (Diluted) came in at -$17.10; for FY2025, it was -$21.76.

  • By year, EPS (Diluted) came in at -$6.22 in FY2024, -$38.03 in FY2023 and -$75.98 in FY2022.
  • The Q2 2026 figure ranks as the lowest quarterly EPS (Diluted) since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.94
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 2.27
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.04
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -0.54
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.67
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.60
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 4.37
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -8.44
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -0.04
10 Nexentis Technologies 494,741.63 -22.15 Mn - -13.66
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -13.66
Dec 31, 2025 6.90
Sep 30, 2025 3.10
Jun 30, 2025 -1.24
Mar 31, 2025 -0.37
Dec 31, 2024 -1.64
Sep 30, 2024 -2.72
Jun 30, 2024 -1.62
Mar 31, 2024 -1.82
Dec 31, 2023 -10.11
Sep 30, 2023 -12.44
Jun 30, 2023 -0.71
Mar 31, 2023 -17.24
Dec 31, 2022 -18.45
Sep 30, 2022 -22.08
Jun 30, 2022 -3.07
API Access

Nexentis Technologies EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=NXTS&period=max&api_key=YOUR_API_KEY